Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer

Martin Sandelin, Georg Holgersson, Christer Janson, Simon Ekman, Michael Bergqvist
European Respiratory Journal 2011 38: p2807; DOI:
Martin Sandelin
1Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Holgersson
2Department of Oncology, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christer Janson
1Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Ekman
2Department of Oncology, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Bergqvist
2Department of Oncology, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Aim: To study the prognostic potential of haemoglobine (Hgb)-, platelet (Plt)- and white blood cell (WBC) levels at time of diagnosis in non-small cell lung cancer (NSCLC) patients.

Background: The search for prognostic and predictive biomarkers in NSCLC is intense. With an increasing number of targeted agents available the present focus is on the genetics of the tumour. However, a majority of all patients lack genetic markers that favour targeted therapies. Thus the need for basic prognostic factors to optimise the treatment for each individual patient is essential

Methods: 833 NSCLC patients, stage I-IV were included in the study. WBC, Plt, Hgb, gender, age at diagnosis, stage, surgery and first-line chemotherapy were studied in relation to overall survival.

Results: For patients with Hgb <110g/L and Hgb >110g/L the median survival was 11.2 and 14.5 months respectively (p=0.0032). For WBC >9.0×109/L and <9.0×109/L the median survival was 11.6 and 15.4 months respectively (p<0.0001). For Plt >350×109/L and <350×109/L the median survival was 11.2 and 14.9 months respectively (p<0.0001). For patients with no pathology in the studied markers compared to those with pathological results in all three markers the median survival were 16.0 and 8.0 months respectively (p<0.0001).

Conclusions: The level of the three studied biomarkers corresponds significantly to outcome. A trend for worsened prognosis is shown when combinations of two pathological markers are present. With all three biomarkers pathological the median survival is halved compared to the group with normal levels. The results are important for the decisions regarding treatment choice and intensity.

  • © 2011 ERS
Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
Martin Sandelin, Georg Holgersson, Christer Janson, Simon Ekman, Michael Bergqvist
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2807;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
Martin Sandelin, Georg Holgersson, Christer Janson, Simon Ekman, Michael Bergqvist
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2807;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • A 55 year old man with bilateral pulmonary nodules, neuropathy and renal nodules
  • Primary posterior mediastinum epithelioid angiosarcoma complicated with pulmonary thromboembolism: A case report
  • Metastatic bronchopulmonary carcinoid
Show more 288. Instructive clinical aspects of lung cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society